Product

Portfolio Intelligence Portside Congress trades Super-investors Economic calendar Earnings calendar Pricing

Company

About FAQs Contact Create account

Legal

Privacy Terms Portside rules

APUS stock Insiders — Apimeds Pharmaceuticals US, Inc. filings, insiders & smart money · Instaport

APUS

Apimeds Pharmaceuticals US, Inc.

COMMON STOCK · NYSE AMERICAN

Price and daily changeSign in

Earnings11 Nov 2026

52-week rangeSign inDay rangeSign in

Market cap: Sign in
Volume: Sign in
Beta: Sign in
Shares float: Sign in
Short interest: 1.32%
P/E (fwd): Sign in
PEG (fwd): Sign in

Price chart (1D to 10Y)

Licensed market data — shown to members, not published to the open web.

Create free account

Overview Statistics Statements Dividends🔒Momentum🔒Quant🔒Fair Value🔒Earnings Analysts🔒Insiders Smart Money Options🔒Insights🔒

Insiders

0 transactions · 0 open-market buys · 0 open-market sells

No Forms 3, 4 or 5 are held for APUS yet.

See the full stock page

Prices, charts, ranges, valuation ratios, dividends, momentum and analyst estimates are licensed for signed-in members. A free account opens every stock, fund and crypto page.

Create free account

Source: SEC filings. Information and analytics, not investment advice.

Loading evidence for APUS

Rev growth (fwd)